Last updated on August 2019

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes


Brief description of study

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medicine). The study will be performed in people with type 2 diabetes. Participants will either get semaglutide or placebo in addition to their diabetes medicines - which treatment the participant gets is decided by chance. Participants will inject the study medicine using a pen-injector. The medicine must be injected in a skin fold in the stomach, thigh or upper arm once a week. The study will last for 5 years.

Clinical Study Identifier: NCT03811561

Find a site near you

Start Over

Novo Nordisk Investigational Site

Los Angeles, CA United States
  Connect »

Novo Nordisk Investigational Site

Walnut Creek, CA United States
  Connect »

Novo Nordisk Investigational Site

West Des Moines, IA United States
  Connect »

Novo Nordisk Investigational Site

Chattanooga, TN United States
  Connect »

Novo Nordisk Investigational Site

San Antonio, TX United States
  Connect »

Novo Nordisk Investigational Site

Shavano Park, TX United States
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Saint-Petersburg, Russian Federation
  Connect »

Novo Nordisk Investigational Site

Hospitalet de Llobregat, Spain
  Connect »

Novo Nordisk Investigational Site

North Yorkshire, United Kingdom
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Jacksonville, FL United States
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

St. Petersburg, Russian Federation
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Rancho Cucamonga, CA United States
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Chesterfield, MO United States
  Connect »

Novo Nordisk Investigational Site

Philadelphia, PA United States
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Chapel Hill, NC United States
  Connect »

Novo Nordisk Investigational Site

Oklahoma City, OK United States
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Huntington Beach, CA United States
  Connect »

Novo Nordisk Investigational Site

Hyattsville, MD United States
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »

Novo Nordisk Investigational Site

Saint Ingbert-Oberwürzbach, Germany
  Connect »